Refreshing results…
KSR1 gene polymorphism in mCRC patients treated with first-line FOLFIRI and bevacizumab.
Download from doi.orgEZH2 polymorphism and benefit from bevacizumab in colorectal cancer: Another piece to the puzzle
Download from www.researchgate.netAn EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patients
Download from www.researchgate.netOutcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimen
Download from www.researchgate.netMissing publications? Search for publications with a matching author name.